Mamoura Diversified Global Holding PJSC is 10% Owner at RECURSION PHARMACEUTICALS, INC. (RXRX). They have made 10 open-market trades across 1 company since 2021, most recently 2023-02-23.
10 open-market purchases totalling $68.8M since 2021, never a sale. Across 10 scored buys the stock is down 15.4% at ninety days, and 17.9 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RXRX | 12,707,805 | $44.0M |
Shares reported on the most recent Form 4, priced at the 2023-02-24 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 0% | 40% |
| Avg Move | +1.5% | -12.0% | -15.4% |
| Alpha | +1.4% | -10.8% | -17.9% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXRX | BUY | 2023-02-23 | 2023-02-24 | $7.79 | $808K | +3.7% | -14.0% | +10.9% |
| RXRX | BUY | 2023-02-22 | 2023-02-23 | $7.83 | $798K | +7.1% | -12.7% | +16.3% |
| RXRX | BUY | 2023-02-21 | 2023-02-22 | $7.74 | $1.5M | +1.6% | -17.2% | +14.5% |
| RXRX | BUY | 2023-02-16 | 2023-02-17 | $7.90 | $674K | +1.3% | -8.2% | -30.8% |
| RXRX | BUY | 2023-02-14 | 2023-02-15 | $7.95 | $50K | -3.2% | -12.0% | -39.1% |
| RXRX | BUY | 2023-02-10 | 2023-02-13 | $7.98 | $88K | -4.5% | -6.1% | -29.7% |
| RXRX | BUY | 2023-01-26 | 2023-01-27 | $7.99 | $126K | -1.5% | -8.4% | -42.0% |
| RXRX | BUY | 2023-01-25 | 2023-01-26 | $7.88 | $387K | +7.7% | -6.2% | -39.6% |
| RXRX | BUY | 2022-12-23 | 2023-01-13 | $7.50 | $14.4M | -10.3% | -12.6% | -28.3% |
| RXRX | BUY | 2021-04-16 | 2021-04-20 | $18.00 | $50.0M | +13.2% | -22.9% | +14.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.